Cargando…
Anticoagulation Therapy Reduces Recurrent Stroke in Embolic Stroke of Undetermined Source Patients With Elevated Coagulation Markers or Severe Left Atrial Enlargement
Background: The objective of this study was to evaluate if anticoagulation therapy reduces recurrent stroke in embolic stroke of undetermined source (ESUS) patients with left atrial enlargement (LAE) or abnormal markers of coagulation and hemostatic activity (MOCHA) compared to antiplatelet therapy....
Autores principales: | Patel, Kishan, Mikhael, Elio, Liu, Michael, Rangaraju, Srikant, Ellis, Deandra, Duncan, Alexander, Belagaje, Samir, Belair, Trina, Henriquez, Laura, Nahab, Fadi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215436/ https://www.ncbi.nlm.nih.gov/pubmed/34163432 http://dx.doi.org/10.3389/fneur.2021.695378 |
Ejemplares similares
-
Markers of coagulation and hemostatic activation aid in identifying causes of cryptogenic stroke
por: Nahab, Fadi, et al.
Publicado: (2020) -
Coagulation markers and echocardiography predict atrial fibrillation, malignancy or recurrent stroke after cryptogenic stroke
por: Ellis, Deandrea, et al.
Publicado: (2018) -
Factors associated with stroke after COVID-19 vaccination: a statewide analysis
por: Nahab, Fadi, et al.
Publicado: (2023) -
Burden of oral anticoagulation in embolic stroke of undetermined source without atrial fibrillation
por: Witte, Klaus K., et al.
Publicado: (2021) -
Embolic stroke of undetermined source: identification of patient subgroups for oral anticoagulation treatment
por: Greeve, Isabell, et al.
Publicado: (2021)